Category: 9th Symposium

Differential diagnosis between depression and neurocognitive impairment in HIV-infected persons

Emerging neurological toxicities in HIV

Substance abuse in HIV-infected patients: what the clinicians should know

Sexuality, substance use and HIV

Neurocognitive disorders in patients with HIV infection with virological suppression > 10 years

New Advanced EEG Technique (LORETA – Low Resolution Electromagnetic Tomography) to Early Detect and Monitor HIV Brain Damage

What do psychiatrists need to know when treating HAND – Differential Diagnosis and HAART neurotoxicity

Transdermal Rivastigmine for HIV-Associated Cognitive Impairment: Preliminary Results from a Randomized

Update for the Conference on Retroviruses and Opportunistic Infections and Summary of the Symposium

Workshop. How to assess neurotoxicity?